David Shang

Stock Analyst at Jefferies

(0.93)
# 4,000
Out of 4,792 analysts
16
Total ratings
35.7%
Success rate
-5.1%
Average return

Stocks Rated by David Shang

Hangzhou Tigermed Consulting Co., Ltd
Sep 2, 2026
Downgraded: Hold
Price Target: $55.00$45.00
Current: $41.84
Upside: +7.55%
WuXi AppTec Co., Ltd.
Aug 4, 2026
Reiterated: Buy
Price Target: $210.00
Current: $192.00
Upside: +9.38%
BioDlink International Company Limited
Jun 8, 2026
Reiterated: Buy
Price Target: $4.40
Current: $3.77
Upside: +16.87%
Adicon Holdings Limited
Mar 31, 2026
Reiterated: Buy
Price Target: $7.00
Current: $4.02
Upside: +74.13%
Shandong Weigao Group Medical Polymer Company Limited
Mar 30, 2026
Reiterated: Buy
Price Target: $5.20$5.50
Current: $3.16
Upside: +74.33%
AK Medical Holdings Limited
Mar 30, 2026
Reiterated: Buy
Price Target: $5.50$7.50
Current: $4.93
Upside: +52.13%
Shanghai MicroPort MedBot (Group) Co., Ltd.
Mar 30, 2026
Reiterated: Buy
Price Target: $35.00$40.00
Current: $21.18
Upside: +88.86%
The United Laboratories International Holdings Limited
Sep 5, 2025
Reiterated: Buy
Price Target: $17.00$20.00
Current: $8.14
Upside: n/a
CSPC Pharmaceutical Group Limited
Jan 22, 2025
Reiterated: Hold
Price Target: $4.60
Current: $8.76
Upside: n/a